Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and the United States of America (USA). The aim of this
clinical trial is to investigate the safety, tolerability, pharmacokinetics (the
determination of the concentration of the administered medication in blood over time) and
pharmacodynamics (the determination of the effect over time and the duration of action) of
multiple doses of liraglutide in the pediatric population (children).